Soares Karen sold $22K of CLOV
Soares Karen (Chief Legal Officer) sold 4,681 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.61 on 2026-06-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the officer’s open-market sale amount, price, and post-transaction holdings, disclosed as part of a pre-arranged 10b5-1 plan.
Market read
Traders may monitor insider activity for sentiment, but this specific disclosure is unlikely to drive a major repricing without additional fundamental catalysts.
What to watch
The article provides only the sale details; it does not indicate whether there were concurrent buys, option exercises, or broader insider activity trends.
Background
The article is an SEC Form 4 insider transaction disclosure for Clover Health Investments, Corp./DE.
Ticker impact
Clover Health’s Chief Legal Officer Karen Soares sold 4,681 shares in an open-market transaction under a pre-arranged 10b5-1 plan.
Likely limited near-term impact; any effect should be small and short-lived unless paired with other news.
The filing is a standard officer sale with a stated 10b5-1 plan, providing disclosure but no new operating/regulatory/financial information.
Market effects
Minimal; this is company-specific insider transaction disclosure, not a sector-wide signal.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as confidence erosion, especially if it clusters with other negative signals.
Key entities
- issuerClover Health Investments, Corp./DE
Subject of the Form 4 insider transaction disclosure.
- insiderKaren Soares
Chief Legal Officer who sold shares under a pre-arranged 10b5-1 plan.
